Skip to main content

Table 1 Patient Characteristics

From: Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

 

CT

BioCT

No.

%

No.

%

No. patients

89

 

87

 

Sex

    

   Male

57

64.0

48

55.2

   Female

32

36.0

39

44.8

Age

    

   Median

59

 

56

 

   Range

26–76

 

25–77

 

Performance status (ECOG)

    

   0

60

67.4

59

67.8

   1

23

25.8

24

27.6

   2

6

6.7

4

4.6

Site of primary melanoma

    

   Head and neck

16

18.0

16

18.4

   Body

35

39.3

36

41.4

   Arms

34

38.2

34

39.1

   Not referred

4

4.5

1

1.1

Sites of disease

    

   Liver +/- others

30

33.7

32

36.8

   Viscera +/- others

29

32.6

31

35.6

   Bone + soft tissue and lymph nodes

4

4.5

2

2.3

   Soft tissue and lymph nodes

26

29.2

22

25.3